Lenalidomide consolidation improves progression free survival in patients with chronic lymphocytic leukemia following initial FCR chemotherapy - final analysis of CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)